|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saintigny P and Burger JA: Recent advances
in non-small cell lung cancer biology and clinical management.
Discov Med. 13:287–297. 2012.PubMed/NCBI
|
|
3
|
Zlotnik A, Burkhardt AM and Homey B:
Homeostatic chemokine receptors and organ-specific metastasis. Nat
Rev Immunol. 11:597–606. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kakinuma T and Hwang ST: Chemokines,
chemokine receptors and cancer metastasis. J Leukoc Biol.
79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keeley EC, Mehrad B and Strieter RM: CXC
chemokines in cancer angiogenesis and metastases. Adv Cancer Res.
106:91–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wald O, Shapira OM and Izhar U:
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic
roles and therapeutic potential. Theranostics. 3:26–33. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu YM, Webster SJ, Flower D and Woll PJ:
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Br J Cancer. 91:1970–1976. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wiley HE, Gonzalez EB, Maki W, Wu MT and
Hwang ST: Expression of CC chemokine receptor-7 and regional lymph
node metastasis of B16 murine melanoma. J Natl Cancer Inst.
93:1638–1643. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mashino K, Sadanaga N, Yamaguchi H, et al:
Expression of chemokine receptor CCR7 is associated with lymph node
metastasis of gastric carcinoma. Cancer Res. 62:2937–2941.
2002.PubMed/NCBI
|
|
11
|
Tsim S, O'Dowd CA, Milroy R and Davidson
S: Staging of non-small cell lung cancer (NSCLC): A review. Respir
Med. 104:1767–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R
and Xiong S: Differential expression of CXCR4 is associated with
the metastatic potential of human non-small cell lung cancer cells.
Clin Cancer Res. 11:8273–8280. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Villena V, López-Encuentra A, García-Luján
R, Echave-Sustaeta J and Martínez CJ: Clinical implications of
appearance of pleural fluid at thoracentesis. Chest. 125:156–159.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brave M, Farrell A, Ching Lin S, et al:
FDA review summary: Mozobil in combination with granulocyte
colony-stimulating factor to mobilize hematopoietic stem cells to
the peripheral blood for collection and subsequent autologous
transplantation. Oncology. 78:282–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Burger JA, Stewart DJ, Wald O and Peled A:
Potential of CXCR4 antagonists for the treatment of metastatic lung
cancer. Expert Rev Anticancer Ther. 11:621–630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Franco R, Pirozzi G, Scala S, et al:
CXCL12-binding receptors expression in non-small cell lung cancer
relates to tumoral microvascular density and CXCR4 positive
circulating tumoral cells in lung draining venous blood. Eur J
Cardiothorac Surg. 41:368–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wagner PL, Hyjek E, Vazquez MF, et al:
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with
metastasis and survival. J Thorac Cardiovasc Surg. 137:615–621.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wald O, Izhar U, Amir G, et al:
Interaction between neoplastic cells and cancer-associated
fibroblasts through the CXCL12/CXCR4 axis: Role in non-small cell
lung cancer tumor proliferation. J Thorac Cardiovasc Surg.
141:1503–1512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yatsunami J, Tsuruta N, Ogata K, et al:
Interleukin-8 participates in angiogenesis in non-small cell, but
not small cell carcinoma of the lung. Cancer Lett. 120:101–108.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan A, Yang PC, Yu CJ, Chen WJ, Lin FY,
Kuo SH and Luh KT: Interleukin-8 messenger ribonucleic acid
expression correlates with tumor progression, tumor angiogenesis,
patient survival and timing of relapse in non-small-cell lung
cancer. Am J Respir Crit Care Med. 162:1957–1963. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Keane MP, Belperio JA, Xue YY, Burdick MD
and Strieter RM: Depletion of CXCR2 inhibits tumor growth and
angiogenesis in a murine model of lung cancer. J Immunol.
172:2853–2860. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sparmann A and Bar-Sagi D: Ras-induced
interleukin-8 expression plays a critical role in tumor growth and
angiogenesis. Cancer Cell. 6:447–458. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gerber PA, Hippe A, Buhren BA, Müller A
and Homey B: Chemokines in tumor-associated angiogenesis. Biol
Chem. 390:1213–1223. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Legler DF, Uetz-von Allmen E and Hauser
MA: CCR7: Roles in cancer cell dissemination, migration and
metastasis formation. Int J Biochem Cell Biol. 54:78–82. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Zhang X, Thomas SM, Grandis JR,
Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates
phosphoinositide-3 kinase-mediated invasive and prosurvival
pathways in head and neck cancer cells independent of EGFR.
Oncogene. 24:5897–5904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takanami I: Overexpression of CCR7 mRNA in
nonsmall cell lung cancer: Correlation with lymph node metastasis.
Int J Cancer. 105:186–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li P, Liu F, Sun L, et al: Chemokine
receptor 7 promotes cell migration and adhesion in metastatic
squamous cell carcinoma of the head and neck by activating integrin
α vβ 3. Int J Mol Med. 27:679–687. 2011.PubMed/NCBI
|
|
29
|
Itakura M, Terashima Y, Shingyoji M, et
al: High CC chemokine receptor 7 expression improves postoperative
prognosis of lung adenocarcinoma patients. Br J Cancer.
109:1100–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Su ML, Chang TM, Chiang CH, Chang HC, Hou
MF, Li WS and Hung WC: Inhibition of chemokine (C-C motif) receptor
7 sialylation suppresses CCL19-stimulated proliferation, invasion
and anti-anoikis. PLoS One. 9:e988232014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shields JD, Kourtis IC, Tomei AA, Roberts
JM and Swartz MA: Induction of lymphoidlike stroma and immune
escape by tumors that express the chemokine CCL21. Science.
328:749–752. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koizumi K, Kozawa Y, Ohashi Y, et al:
CCL21 promotes the migration and adhesion of highly lymph node
metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol
Rep. 17:1511–1516. 2007.PubMed/NCBI
|
|
33
|
Zhang Q, Sun L, Yin L, Ming J, Zhang S,
Luo W and Qiu X: CCL19/CCR7 upregulates heparanase via specificity
protein-1 (Sp1) to promote invasion of cell in lung cancer. Tumour
Biol. 34:2703–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu J, Zhao J, Feng H, et al: Antitumor
efficacy of CC motif chemokine ligand 19 in colorectal cancer. Dig
Dis Sci. 59:2153–2162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hillinger S, Yang SC, Zhu L, et al:
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes
IFN-gamma-dependent antitumor responses in a lung cancer model. J
Immunol. 171:6457–6465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hillinger S, Yang SC, Batra RK, Strieter
RM, Weder W, Dubinett SM and Sharma S: CCL19 reduces tumour burden
in a model of advanced lung cancer. Br J Cancer. 94:1029–1034.
2006. View Article : Google Scholar : PubMed/NCBI
|
